Moreover, IGFBP7, initially identified by us as a protein that is downregulated with disease progression in BC (Burger et al, 1998; Landberg et al, 2001), was described as a stem cell marker expressed in CD44+, but not in CD24+ cell fractions of normal and BC tissues (Shipitsin et al, 2007). The gene discussed is CD44; the disease is breast cancer.